MedTrace Logo

The Efficacy of Laser in Root Canal Disinfection

NCT05964686 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-11-29

No results posted yet for this study

Summary

The aim of this study is to assess in vivo the efficacy of Er,Cr:YSGG/diode laser and Diode/EDTA on bacterial count in root canal treatment in an evidence-based clinical trial. The null hypothesis being tested is that there is no difference in total bacterial count reduction between conventional irrigation and the two types of lasers used.

Thirty patients are equally divided into 3 separate groups :

* Group A (Conventional): 2.5% NaOCL and 17% EDTA.
* Group B(Dual): saline along with Er,Cr:YSGG laser and diode laser combination
* Group C(Combined): saline along with 17% EDTA and diode laser combination Microbiological analysis will be done for both aerobic and anaerobic bacteria using Colony forming units. All data will be collected, tabulated, summarized, and statistically analyzed.

Conditions

  • Pulp and Periapical Tissue Disease
  • Pulp Necroses
  • Pulp; Granuloma

Interventions

COMBINATION_PRODUCT

Conventional group (NaOCl/EDTA)

conventional disinfection using 2.5% sodium hypochlorite and 17% EDTA

COMBINATION_PRODUCT

Dual laser group (Er,Cr:YSGG/Diode):

Er,Cr:YSGG intracanal laser irradiation to remove smear layer followed by diode laser for disinfection

COMBINATION_PRODUCT

Combined group (EDTA/Diode):

17% EDTA was used to remove smear layer followed by diode laser for disinfection

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Future University in Egypt

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-09-30
Completion
2022-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05964686 on ClinicalTrials.gov